000963 logo

Huadong Medicine Co., Ltd Stock Price

SZSE:000963 Community·CN¥72.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

000963 Share Price Performance

CN¥41.17
4.59 (12.55%)
CN¥41.17
4.59 (12.55%)
Price CN¥41.17

000963 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

1 Risk
4 Rewards

Huadong Medicine Co., Ltd Key Details

CN¥43.1b

Revenue

CN¥28.5b

Cost of Revenue

CN¥14.6b

Gross Profit

CN¥10.9b

Other Expenses

CN¥3.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.11
33.89%
8.58%
8.9%
View Full Analysis

About 000963

Founded
1993
Employees
18265
CEO
Liang Lv
WebsiteView website
www.eastchinapharm.com

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment. It also manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs; and engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides business, leasing, and warehousing services. It also develop small nucleic acid (siRNA) drug SNK-2726, an angiotensinogen (AGT) for the treatment of hypertension. Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

Recent 000963 News & Updates

Recent updates

No updates